Hainan Shuangcheng Pharmaceuticals Co., Ltd.
HNSP was founded in 2000 and is a
publicly-traded company. We engage in development, manufacturing and marketing
of both APls and drug products. We have more than 10 management members with
oversea doctor degree and also oversea experience in R&D, manufacture
and/or registration. HNSP enjoys a strong team of regulatory registration,
and also a China-based sales force of over 400 agents. With excellent know-how
in peptide chemistry, HNSP is a leader in the field of peptide manufacture in
Most of our facilities were built based on the EU and US CGMP standards.
HNSP has been inspected respectively by USFDA and (Italy) AIFA and the GMP status was considered acceptable and spoken highly of.
Our Thymalfasin API and FDF has also been approved by (Italy) AIFA.We are open to discuss any forms of collaborations.
|Sales markets||Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America|
|Primary business activity||Manufacturer|
|Affiliated categories:||Peptides |Finished Dosage Forms More|
Our Top products
Aciclovir for injection (0.25g)
Hainan Shuangcheng Pharmaceuticals Co. manufactures apis and generic finished dosage products which includes aciclovir for injection (0.25g). It belongs to finished dosages products category. Contact us for more information.More info
Adenosine cyclophosphate for injection (20mg)
Hainan Shuangcheng Pharmaceuticals Co. manufactures apis and generic finished dosage products which includes adenosine cyclophosphate for injection (20mg). It belongs to finished dosages products category. Contact us for more information.More info
WebsiteView all contact information
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation